Target intelligence / Profile preview

Dietary triacylglycerol (TAG)

Target
TAG
Molecular classification
Lipid, Nutrient, Substrate, Other
01

Overview

Dietary triacylglycerols (TAGs) are the predominant form of dietary lipid, consisting of three fatty acids esterified to a glycerol backbone (StatPearls, 2023). In the intestinal lumen, these fats must be emulsified by bile salts and subsequently hydrolyzed by enzymes, primarily pancreatic lipase, into free fatty acids and 2-monoacylglycerols to be absorbed by the intestinal mucosa (NIH, 2022). While they serve as a critical energy source and are necessary for the absorption of fat-soluble vitamins (A, D, E, and K), chronic excessive intake is a major driver of obesity, metabolic syndrome, and cardiovascular disease (PubMed, 2021). Pharmacological strategies typically do not target the fats directly but rather the processes governing their digestion; for instance, the drug Orlistat functions by inhibiting gastric and pancreatic lipases, preventing the breakdown of TAGs and thus reducing their absorption by approximately 30% (PubChem, 2024). This leads to the presence of undigested fats in the distal intestine, which can cause side effects such as steatorrhea and potential deficiencies in lipophilic nutrients.

Other names
TriglycerideDietary fatNeutral fatTriacylglycerols
02

Mechanism of action

Inhibition of enzymatic hydrolysis by pancreatic lipase, preventing the breakdown of triacylglycerols into absorbable fatty acids and monoglycerides; sequestration of bile acids to impair lipid emulsification; use of non-absorbable fat substitutes.

03

Biological functions

Energy storageFat-soluble vitamin absorptionMetabolic fuel sourceOther
04

Disease associations

ObesityHyperlipidemiaCardiovascular diseaseMalabsorption syndromeSteatorrheaOther
05

Safety considerations

SteatorrheaMalabsorption of fat-soluble vitamins (A, D, E, K)Gastrointestinal distressOily spotting
06

Interacting drugs

Orlistat

3 more in the full profile.

07

Biomarkers

Fecal fat excretionSerum triglyceride levelsPostprandial lipid profile

Beyond the preview

Go deeper on Dietary triacylglycerol (TAG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dietary triacylglycerol (TAG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call